El Paso Electric Company (EE) is Trading Lower on Unusual Volume for February 03

Equities Staff  |

El Paso Electric Company (EE) experienced unusually high volume on Feb. 03, as the stock lost 0.37% to a closing price of $42.61. The stock saw 597,514 shares trade hands over the course of the day on 2,386 trades. Given that the stock’s average daily volume over the last month has been 209,222 shares a day, this represents a pretty substantial spike over the norm.

El Paso Electric Company has a P/B ratio of 1.69. It also has a P/E ratio of 18.1. The stock has traded between $42.96 and $33.77 over the last 52-weeks, its 50-day SMA is now $38.23, and its 200-day SMA $36.51.

El Paso Electric Co is a public utility company. The Company is engaged in the generation, transmission and distribution of electricity in west Texas and southern New Mexico.

Headquartered in El Paso, TX, El Paso Electric Company has 1,000 employees and is currently under the leadership of CEO Mary E. Kipp.

For a complete fundamental analysis analysis of El Paso Electric Company, check out Equities.com’s Stock Valuation Analysis report for EE. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…